In vitro experiments found that the SIRT1 activator SRT2104 further decreased the growth rate of B-ALL cell lines (NALM6 and REH) depressed by vincristine (Figures 5A, B). The gene discussed is SIRT1; the disease is acute lymphoblastic leukemia.